Image Source: ScanX
Prism Medico and Pharmacy Limited has approved a preferential issue of 7.5 million equity shares and 5 million convertible warrants at Rs. 20 each. The total fundraise amounts to Rs. 25 crore, subject to shareholder approval at the Extraordinary General Meeting scheduled for March 20, 2026.
Show more
Prism Medico and Pharmacy Limited has announced key capital-raising measures following its board meeting on February 23, 2026. The company plans to issue equity shares and convertible warrants to promoters and non-promoters, strengthening its financial base and expanding ownership.
Key Highlights
-
Alteration of Article 15 in the Articles of Association to allow issuance of securities via preferential offer or private placement
-
Approval for issuance of 75,00,000 equity shares priced at Rs. 20 each, aggregating Rs. 15 crore
-
Approval for issuance of 50,00,000 convertible warrants priced at Rs. 20 each, aggregating Rs. 10 crore
-
Convertible warrants carry a 1:1 conversion ratio, exercisable within 18 months, with 25% payable upfront and 75% at conversion
-
Promoter investors include Symbiosis Pharmaceuticals Pvt Ltd and Galaxy Vitacare Pvt Ltd; non-promoter investors include Dharmender Kharb and Raju Tyagi among others
-
Post-preferential allotment, combined promoter and non-promoter holdings will rise to 74.72% of equity capital
-
Shareholder approval will be sought at the Extraordinary General Meeting on March 20, 2026, via video conferencing
Source: Prism Medico and Pharmacy Limited, BSE Limited, Metropolitan Stock Exchange of India Limited
Stay Ahead – Explore Now!
Silver Prices Surge 5.33% on February 23; City-Wise Rates Across India
Advertisement
STORIES YOU MAY LIKE
Image Source: LinkedIn
Updated: February 23, 2026 17:25
Image Source: SharkTankSeason
Updated: February 22, 2026 19:20
Image Source: LinkedIn
Updated: February 21, 2026 19:24
Advertisement